August 23, 2019
Targeting the Epigenetic Drivers of Cancer
Read More
August 22, 2019
Retrophin PKAN Therapy Fails in Late Stage Trial
Read More
August 22, 2019
Cerecor Receives Fast Track Designation for Rare Metabolic Disorder Therapy
Read More
August 20, 2019
FDA Rejects Sarepta DMD Drug Because of Safety Concerns
Read More
August 19, 2019
FDA Approves Celgene’s Treatment for Rare Bone Cancer
Read More
August 19, 2019
FDA Approves Genentech’s Rozlytrek to Treat Two Rare Cancers
Read More
August 16, 2019
Tackling Kidney Diseases with Orally-Delivered Enzymes
Read More
August 15, 2019
Ultragenyx Enters Partnership with GeneTx to Develop Angelman Syndrome ASO
Read More
August 13, 2019
Pharming Acquires Late-Stage Novartis Drug to Treat Ultra-Rare Immune Disorder
Read More
August 12, 2019
ProQR Gets FDA Clearance to Start Clinical Trial to Treat Rare Eye Disease
Read More
August 12, 2019
Immunic Says First Patient Enrolled in Proof-of-Concept Trial for Rare Liver Disease Therapy
Read More
August 9, 2019
Giving Voice to Patients through Data
Read More
Load More
X